“‘Experts in TB control had declared MDR treatment inordinately costly, but no one had tried to reduce the main expense, which was high-priced drugs.” It was discovered that the patents on most of those drugs had expired, but no one had sought to create inexpensive generic versions of them, because there was “no market.’”
— Aug 13, 2026 11:34AM
Add a comment